Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (9658)	8/23/2006 10:39:32 AM
From: Robohogs	Respond to of 10280

You are correct from what I understand and you also have going for you the quick bounces in the mid 40s before. If I held no shares of SEPR, I would surely sell some puts. And if I had gotten the vol spike, I surely would have. Want to share? LOL Good luck BTW. Jon

To: tuck who wrote (9658)	8/26/2006 7:53:33 PM
From: ritzkid8	Read Replies (2) \| Respond to of 10280

>Oddly, I think more concrete is the floor provided by the products as you mention added to the possibility the company is for sale< With all due respect, I think it's wishful thinking if you think Sepracor is finding support a these levels because of the products versus the possibility of a buyout. Lunesta is a best in class product but this company has failed in its attempt to maximize the potential this product has. One expansion (Spring of '06) and 200M direct to consumer dollars later and the weekly trend line has been flat for almost a year. If that isn't enough, this stock hasn't provided any kind of return for investors for almost five years. Buyout rumors are the only thing that has driven this stock up over the past two years and a buyout will be the only thing that drives it in the future.